Literature DB >> 1422980

Histochemical and fine structural study of bone of ipriflavone-treated rats.

H Ozawa1, H Nakamura, K Irie, M Irie.   

Abstract

Bone labeling, histochemical, and fine structural studies were performed in order to clarify the effects of ipriflavone (IP) on rat bone tissue in vivo and in vitro. Labeling experiments showed a slight increase in bone formation during 3 days' administration. It was also noted that many osteoclasts detached from the bone surface at 1, 2, and 6 hours after administration in vivo. In addition, irregular localization of tartrate-resistant acid phosphatase (TRACPase) activity was observed in osteoclasts. Fine structurally, IP-treated osteoclasts exhibited irregularity in their ruffled borders, as reported in calcitonin administration, and many enlarged rough endoplasmic reticuli and vacuoles were observed. However, osteoclasts at 12 hours after administration, as well as the control, indicated recovery features from the effect of IP. Osteoblast proliferation and differentiation led to increasing alkaline phosphatase activity (ALPase) with time as well as the development of rough endoplasmic reticuli and Golgi apparatus with well-developed fine structure. These findings imply active synthesis of bone matrix. In our in vitro experiment, osteoclasts and osteoblasts displayed histochemical and fine structural characteristics similar to those observed in our in vivo experiment. Moreover, fewer TRACP-positive mononuclear cells were observed after 24-hour culture with IP than with the control. These results suggest that IP inhibits directly and/or indirectly differentiation and activity of osteoclasts and also promotes differentiation of osteoblast-lineage cells and their bone-forming activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1422980     DOI: 10.1007/bf02180245

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  9 in total

1.  Ipriflavone inhibits osteoclast differentiation in parathyroid transplanted parietal bone of rats.

Authors:  E Bonucci; P Ballanti; A Martelli; E Mereto; G Brambilla; P Bianco; L Bufalino
Journal:  Calcif Tissue Int       Date:  1992-04       Impact factor: 4.333

2.  Effects of ipriflavone and its metabolites on a clonal osteoblastic cell line.

Authors:  S Benvenuti; A Tanini; U Frediani; S Bianchi; L Masi; R Casano; L Bufalino; M Serio; M L Brandi
Journal:  J Bone Miner Res       Date:  1991-09       Impact factor: 6.741

3.  Effect of flavonoid on PGE2-induced alterations in percentage collagen synthesis in ossicle organ cultures.

Authors:  O Ribári; I Sziklai
Journal:  Acta Otolaryngol       Date:  1987 May-Jun       Impact factor: 1.494

4.  Avian osteoclasts as estrogen target cells.

Authors:  M J Oursler; P Osdoby; J Pyfferoen; B L Riggs; T C Spelsberg
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

5.  The effect of ipriflavone (TC-80) on bone resorption in tissue culture.

Authors:  M Tsuda; T Kitazaki; T Ito; T Fujita
Journal:  J Bone Miner Res       Date:  1986-04       Impact factor: 6.741

6.  Calcitonin secreting property of ipriflavone in the presence of estrogen.

Authors:  I Yamazaki; M Kinoshita
Journal:  Life Sci       Date:  1986-04-28       Impact factor: 5.037

7.  Effect of ipriflavone on the response of uterus and thyroid to estrogen.

Authors:  I Yamazaki
Journal:  Life Sci       Date:  1986-02-24       Impact factor: 5.037

8.  Effect of ipriflavone on glucocorticoid-induced osteoporosis in rats.

Authors:  I Yamazaki; A Shino; Y Shimizu; R Tsukuda; Y Shirakawa; M Kinoshita
Journal:  Life Sci       Date:  1986-03-10       Impact factor: 5.037

9.  The effect of flavone treatment on human otosclerotic ossicle organ cultures.

Authors:  I Sziklai; O Ribári
Journal:  Arch Otorhinolaryngol       Date:  1985
  9 in total
  4 in total

1.  Lack of effect of ipriflavone on osteoclast motility and bone resorption in in vitro and ex vivo studies.

Authors:  K Notoya; S Taketomi; M Tsuda
Journal:  Calcif Tissue Int       Date:  1993-07       Impact factor: 4.333

2.  Increase in femoral bone mass by ipriflavone alone and in combination with 1 alpha-hydroxyvitamin D3 in growing rats with skeletal unloading.

Authors:  K Notoya; K Yoshida; R Tsukuda; S Taketomi; M Tsuda
Journal:  Calcif Tissue Int       Date:  1996-02       Impact factor: 4.333

3.  Inhibitory effect of ipriflavone on pit formation in mouse unfractionated bone cells.

Authors:  K Notoya; K Yoshida; S Taketomi; I Yamazaki; M Kumegawa
Journal:  Calcif Tissue Int       Date:  1992       Impact factor: 4.333

4.  Inhibitory effect of ipriflavone on osteoclast-mediated bone resorption and new osteoclast formation in long-term cultures of mouse unfractionated bone cells.

Authors:  K Notoya; K Yoshida; S Taketomi; I Yamazaki; M Kumegawa
Journal:  Calcif Tissue Int       Date:  1993-09       Impact factor: 4.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.